Alignment with Award Category
Dr. Badmaevâs research and innovations align seamlessly with the Industry Impact Award criteria. His pioneering work in natural pharma and smart drug development, along with his numerous patents and product contributions, make him a highly deserving candidate.
American Medical Holdings Inc. | United States
Profile
Orcid
Scopus
đEarly Academic PursuitsÂ
Education and Training
Vladimir Badmaev, MD, PhD, embarked on his academic journey at the Medical Academy of Bialystok (AMB) in Poland, where he graduated in 1975. His early academic years laid a strong foundation in medical sciences, leading him to specialize in clinical and anatomical pathology. He pursued his specialization at Kings County Hospital, New York, and Downstate Medical Center, New York, between 1982 and 1985. During this period, he honed his expertise in understanding disease mechanisms and diagnostic techniques. Additionally, in 1978, he obtained his PhD in immunopharmacology from AMB, reflecting his deep interest in the interaction between the immune system and pharmacological agents. His academic credentials positioned him as a leader in integrative medicine, combining traditional knowledge with scientific advancements.
đźProfessional EndeavorsÂ
Academic Positions
Dr. Badmaevâs professional career has been defined by his dedication to bridging traditional botanical medicine with modern pharmacological science. In 1984, he established the Badmaev Natural Drug Foundation, an organization committed to exploring the therapeutic potential of natural compounds. Later, in 2009, he founded American Medical Holdings Inc. in Staten Island, New York, to advance the development of nutraceuticals and natural pharmaceutical products. Through these initiatives, he has played a crucial role in integrating the principles of traditional medicine with contemporary scientific research. His company, www.badmaevtradition.com, stands as a testament to his lifelong commitment to safe and effective alternative medicine solutions.
đContributions and Research Focus on Pharma
Dr. Badmaev has dedicated his career to the research and development of nutraceuticals and natural pharmaceutical products. He conceptualized the Interactive Nutrients Process (INP), a method that integrates the knowledge of botanicals with pharmacological science to develop âsmart drugsâ using artificial intelligence. His work has been instrumental in the advancement of various nutraceutical formulations, including C3ComplexÂŽ (Sabinsa), GugulipidÂŽ (Sabinsa), SeleniumSelectÂŽ (Sabinsa), LactosporeÂŽ (Sabinsa), XanthigenÂŽ (PLThomas), RhodioLifeÂŽ (PLThomas/Polyphenoles Naturales), ZembrinÂŽ (PLThomas/HGH), 5-LoxinÂŽ/Apres-FlexÂŽ (PLThomas), and MenaQ7ÂŽ (NattoPharma). Furthermore, he has been actively involved in developing natural therapeutics such as AdaptrinÂŽ, GreenSeleniumÂŽ, TurmericImmuneÂŽ, SlimTrymÂŽ, and FB3ÂŽ under American Medical Holdings Inc. His recent work focuses on the natural ginger phenolic derivative, 6-Shogaol, for managing iron overload and early-stage myelodysplastic syndromes (MDS). This breakthrough has resulted in a US patent, No.: US 10,864,174 B2 (2017), along with 11 related patents worldwide (2017-2024).
đAccolades and RecognitionÂ
Between 1999 and 2009, Dr. Badmaev was the runner-up or recipient of four New Jersey R&D Council Thomas Alva Edison Awards. These accolades were awarded in recognition of his contributions to scientific research and patent innovations, including US patents #5,536,506, #5,804,596, #6,849,645, and #7,063,861. His extensive work in the field of nutraceutical research has earned him international recognition, leading to collaborations and multiple patent approvals in various countries, including Australia, Canada, New Zealand, Mexico, Brazil, South Africa, the European Community, Japan, Korea, India, and China.
đ Impact and InfluenceÂ
Community Impact
Dr. Badmaevâs influence extends beyond research and development. His contributions to literature have enriched the understanding of traditional medicineâs integration with modern healthcare. In 1999, he authored a chapter on Tibetan medicine in a medical textbook for students and healthcare professionals, edited by Wayne Jonas and Jeffrey Levine. A decade later, in 2009, he contributed to a chapter on curcuminoids in a book on alternative treatments in medicine by Raymond Cooper and Fredi Kronenberg. His scholarly work has provided valuable insights into the therapeutic applications of botanical medicine.
đŽLegacy and Future ContributionsÂ